20900 ⎘
Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Peptides having 5 to 11 amino acids
Treatments for Gastrointestinal Disorders
#602Pharmacokinetics and cholecystokinin-2 receptor (CCK2R) targeting for diagnosis and therapy
#603SARS-CoV-2 epitope-targeted peptide immunostimulants
#604COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING LUNG DISEASE
#605Antibodies targeting a complex comprising non-classical HLA-I and neoantigen and their methods of use
#606GENERATION OF BRAIN AND SPINAL CORD NEURONS, CARDIAC MYOCYTES, AND HEPATOCYTES USING REG PEPTIDES, PEPTIDOMIMETICS, SMALL MOLECULES AND STIMULATORY ANTIBODIES TO REG RECEPTOR
#607Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making
#608Peptide exhibiting wrinkle-improving activity and uses thereof
#609COMPOSITIONS AND METHODS FOR POTENTIATING IMMUNE CHECKPOINT INHIBITOR THERAPY
#610Storage stable sincalide formulations
#611METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF
#612CHONDROINDUCTIVE PEPTIDES AND COMPOSITIONS AND METHODS OF USE THEREOF
#613Oral formulations of kappa opioid receptor agonists
#614Application of Dalargin for the prevention of VRIs and prevention of the development of complications during VRIs
#615COMPOSITIONS AND METHODS FOR IMPROVING BRUISING AND REJUVENATING SKIN
#616Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#617Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#618Liposomal compositions and methods of use
#619THERAPEUTIC PEPTIDES AND METHODS FOR TREATING AUTOIMMUNE RELATED DISEASE
#620POLYPEPTIDE THERAPEUTICS AND USES THEREOF
#621Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#622Children Blood Transfusion and Thymus Hormonal Therapy as Antiviral and Antibacterial Compounds
#623Peptides for the treatment of covid-19
#624Intranasal administration
#625Methods for Reducing Perinatal Morbidity and / or Mortality
#626PEPTIDES AND COMPOSITIONS FOR TARGETED TREATMENT AND IMAGING
#627Peptides and combination thereof for use in the immunotherapy against cancers
#628Compositions and methods for treatment of acute lung injury
#629RESPIRATORY TREATMENTS USING SALMONID OIL COMPOSITIONS
#630PEPTIDE NANOPARTICLES AND USES THEREFOR
#631COMPOSITIONS AND METHODS FOR TREATING DISEASE ASSOCIATED WITH PERMEABILITY OF INTESTINAL EPITHELIUM
#632Methods, Systems and Apparatus for Reducing Pathogen Loads in Circulating Body Fluids
#633SYSTEMS, METHODS, AND KITS FOR DIAGNOSTICS AND TREATMENT OF VIRAL RESPIRATORY INFECTION
#634SYSTEMS, METHODS, AND KITS FOR DIAGNOSTICS AND TREATMENT OF VIRAL RESPIRATORY INFECTION
#635Systems, methods, and kits for diagnostics and treatment of viral respiratory infection
#636Heparin conjugated to collagen-binding peptides for targeting to biological and synthetic tissues
#637Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
#638Bioconjugates with chemically modified backbones
#639Compositions and methods of targeting cancer stem cells
#640Protein biomarkers for diseases associated with the contact activation system
#641Cell-permeable inhibitory agent and methods of use thereof in treatment of cognitive and mood disorders
#642Compositions for neuromodulation of mosquito feeding behavior and uses thereof
#643B*44 restricted peptides for use in immunotherapy against cancers and related methods
#644Intranasal administration
#645TREATMENTS FOR IMPROVING OR LESSENING IMPAIRMENT OF MITOCHONDRIAL FUNCTION
#646Methods for diagnosis and treatment of type 1 diabetes
#647INFLAMMATORY SKIN DISORDER TREATMENT
#648LLP2A-BISPHOSPHONATE CONJUGATES FOR OSTEOPOROSIS TREATMENT
#649METHODS FOR ATTENUATING RELEASE OF INFLAMMATORY MEDIATORS AND PEPTIDES USEFUL THEREIN
#650Dry powder formulation of caveolin-1 peptides and methods of use thereof
#651Anti-neurodegenerative therapeutic, method of manufacture, and use
#652Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#653Tandem repeat cancer-targeting peptides for molecular conjugation or engineering and uses thereof in cancer theranostics
#654Conjugates of a glycoprotein or a glycan with a toxic payload
#655PIC1 inhibition of myeloperoxidase oxidative activity in an animal model
#656METHODS FOR ENHANCING IMMUNOTHERAPY IN THE TREATMENT OF CANCER
#657ORAL PEPTIDE ANTAGONISTS OF MULTIPLE CHEMOKINE RECEPTORS FOR REVERSING LOSS OF SYNAPSES AND DENDRITIC SPINES
#658Nutritional Supplements Containing A Peptide Component And Uses Thereof
#659Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#660COMBINATION THERAPIES FOR TREATMENT OF CANCER
#661Treatment of cancer with larazotide derivatives in combination with immune checkpoint inhibitors
#662B*44 restricted peptides for use in immunotherapy against cancers and related methods
#663Methods and compositions for theranostic nanoparticles
#664Compositions and methods for treating glioblastoma
#665PHARMACEUTICAL COMPOSITION AND A METHOD FOR ITS MANUFACTURE
#666Arid5a peptide inhibitors
#667NATURAL NANOPARTICLE-MEDICINE COMPOSITION FOR TREATING ALZHEIMER'S DISEASE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#668PEPTIDE VACCINE THERAPY FOR TREATMENT OF FRa-EXPRESSING TUMORS
#669Peptides and combination of peptides of non- canonical origin for use in immunotherapy against different types of cancers
#670Compositions and methods for invasive and non-invasive procedural skincare
#671Peptide for preventing skin damage caused by air pollutants and for anti-aging, and use thereof
#672MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#673Cancer-specific T-cell receptors
#674PEPTIDES FOR USE IN PROMOTING TRANSPORT OF GLUCOSE
#675NEW PHARMACEUTICAL USE
#676HIF-1 and HIF-2 inhibitors
#677Peptides and combination of peptides for use in immunotherapy against various tumors
#678Peptides and combination of peptides for use in immunotherapy against various tumors
#679PEPTIDES OF USE IN THE PREVENTIVE AND CURATIVE TREATMENT OF ALOPECIA
#680Methods and compositions for use of a chemokine receptor antagonist peptide to treat addiction, substance abuse disorders or symptoms thereof
#681Peptides and combination of peptides for use in immunotherapy against various tumors
#682MOLECULAR BACTERIOTHERAPY TO CONTROL SKIN ENZYMATIC ACTIVITY
#683ENOLASE 1 (ENO1) COMPOSITIONS AND USES THEREOF
#684COMPOSITIONS AND METHODS FOR POTENTIATING IMMUNE CHECKPOINT INHIBITOR THERAPY
#685Antimicrobial peptide stimulating cleansing composition
#686Peptidyl inhibitors of calcineurin-NFAT interaction
#687SUSTAINED RELEASE PEPTIDE FORMULATIONS
#688METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISORDERS AND ALZHEIMER'S DISEASE AND IMPROVING NORMAL MEMORY
#689IMPLANTABLE DEVICE FOR THE DELIVERY OF OCTREOTIDE AND METHODS OF USE THEREOF
#690Method for accelerated healing of burn wounds
#691Phosphorylcholine conjugates and uses thereof
#692Pharmaceutical Compositions Including Low Dosages of Desmopressin
#693CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#694CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#695Degradable thiol-ene polymers and methods of making thereof
#696FORMULATIONS FOR A TIGHT JUNCTION EFFECTOR
#697COMPOSITION COMPRISING VEGF ANTAGONISTS AND A CATIONIC PEPTIDE AND USES THEREOF
#698Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#699Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#700Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#701Topical formulations comprising montelukast and combinations with mussel adhesive proteins
#702NOVEL TREATMENT APPROACH BY TARGETED DELIVERY OF BIOACTIVE MOLECULES BIO MODULATED CERAMICS
#703CATIONIC PEPTIDES WITH IMMUNOMODULATORY AND/OR ANTI-BIOFILM ACTIVITIES
#704Manufacture of degarelix
#705Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#706Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#707COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CEREBRAL ATROPHY
#708TRPV3 agonists for the treatment of skin conditions
#709Inhibitors of metastasis
#710COMBINATORIAL ANDROGEN DEPRIVATION WITH AN ANDROGEN RECEPTOR VACCINE
#711Q-peptide hydrogel promotes immune modulation and macrophage differentiation
#712Method of treating prostate cancer with GnRH antagonist
#713Adiponectin peptidomimetics for treating ocular disorders
#714Dosing regimens for echinocandin class compounds
#715Linear lipopeptide paenipeptins and methods of using the same
#716Antiviral methods and compositions comprising probiotic bacterial molecules
#717STABLE PARENTERAL DOSAGE FORM OF CETRORELIX ACETATE
#718CHANNEL MODULATORS
#719NANOMOLECULES FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES
#720Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#721Methods of treating Prader-Willi syndrome
#722Method of treating and prognosing scoliotic patient subgroups
#723DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS
#724CEACAM based antibacterial agents
#725Drug delivery systems comprising a neurotrophic agent, an apoptosis signaling fragment inhibitor (FAS) or FAS ligand (FASL) inhibitor, a tumor necrosis factor-alpha (TNF-alpha) or TNF receptor inhibitor, a mitochondrial peptide, an oligonucleotide, a chemokine inhibitor, or a cysteine-aspartic protease inhibitor
#726COMPOSITIONS AND METHODS OF USING SAME FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS)
#727COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING GASTROINTESTINAL DAMAGE ASSOCIATED WITH NSAID THERAPY
#728Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#729B*44 restricted peptides for use in immunotherapy against cancers and related methods
#730Sincalide Formulations
#731Method for preparing biodegradable microspheres using stabilized single-phase mixed solution
#732Cyclic compound/peptide comprising an A-beta13-16 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-beta13-16 peptide
#733Cyclic compound/peptide comprising an A-beta15-18 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-BETA15-18 peptide
#734NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML AND OTHER CANCERS
#735NOVEL COMPOSITION
#736Phage-peptide constructs for stimulating an immune response against CD47
#737Therapeutic and Neuroprotective Peptides
#738Implantable medical device having a negatively-charged and antimicrobial surface
#739IMPROVED PEPTIDE PHARMACEUTICALS
#740ORAL OCTREOTIDE ADMINISTERED IN COMBINATION WITH OTHER THERAPEUTIC AGENTS
#741Peptides Having Anti-Inflammatory Properties
#742Method of treating a philadelphia chromosome-positive tumor
#743Manufacture of Degarelix
#744Means and methods for treating bacterial infections
#745BIOACTIVE GREEN-LIPPED MUSSEL EXTRACTS AND USES THEREOF
#746Compositions and methods for treating diseases by inhibiting exosome release
#747Stemness-suppressing composition comprising OCT4 function-inhibiting peptide
#748COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING HYPERGLYCEMIA, INSULIN RESISTANCE, AND ASSOCIATED ORGAN DAMAGE
#749Compositions and methods of treating cancer with glycomimetic peptides
#750Phosphorylcholine conjugates and uses thereof
#751Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#752Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers
#753Light-Controlled Antibacterial Agent Composed of Linear Cationic Oligopeptide and Multi-arm B-Cyclodextrin
#754Intracellular IL-1 alpha peptide methods and compositions
#755THERAPEUTIC HOMODIMER AND USES THEREOF
#756ZINC ACTIVATED THYMULIN AND METHODS OF PREPARATION AND ADMINISTRATION
#757Methods of reducing neuroinflammation or toxicity induced by amyloid beta (abeta) using glucocorticoid induced leucine zipper (GILZ) analog peptides
#758Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#759Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#760Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#761Affinity ligands for antibody Fc region
#762Inhibitors of β integrin-G protein α subunit binding interactions
#763Method of treating diseases
#764Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#765Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#766Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#767Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#768Methods for reducing CD36 expression
#769OCA-B peptide conjugates and methods of treatment
#770Methods for Increasing the Selective Efficacy of Gene Therapy Using CAR Peptide and Heparan-Sulfate Mediated Macropinocytosis
#771COMBINATORIAL THERAPIES FOR THE TREATMENT OF NEOPLASIAS USING THE OPIOID GROWTH FACTOR RECEPTOR
#772HPV IMMUNOTHERAPY
#773Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
#774Cyclic peptidyl inhibitors of CAL-PDZ binding domain
#775Polypeptides having anti-senescent effects and uses thereof
#776Compositions and methods for treating vaginal dryness
#777Compositions comprising cyclic peptides derived from an A-beta peptide
#778METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY
#779Compositions and methods for treating or preventing intestinal paracellular permeability
#780MUTANT HSP70i TO PREVENT AUTOIMMUNE DISEASE
#781Disruption of the WAVE3 protein complex for suppression of invasion and metastasis
#782Block copolymers
#783Peptides and related compositions and methods
#784Treatment of inflammation
#785ACTIVATION AND EXPANSION OF NKG2C+ NK CELLS
#786Bacterial-binding peptides for treatment of infectious diseases and related inflammatory processes
#787CONJUGATE OF CYTOTOXIC DRUG AND PRODRUG FORM OF SAID CONJUGATE
#788Sunflower seed protein-derived peptides
#789Targeted Doxorubicin-Gold Nanocojugates for Tumor Therapy
#790Composition and methods for promoting and treating chronic wound healing
#791METHODS FOR REDUCING OXIDATIVE DAMAGE
#792REDUCING CUTANEOUS SCAR FORMATION AND TREATING SKIN CONDITIONS
#793Arid5a peptide inhibitors
#794ENDOSTATIN PEPTIDES FOR THE TREATMENT OF TUMORS, FIBROSIS AND ACUTE LUNG INJURY
#795Peptides and methods for treating disease
#796Formulations containing a somatostatin receptor agonist
#797Peptide therapies for reduction of macular thickening
#798Fatty acids and their use in conjugation to biomolecules
#799Antimicrobial compositions and methods of use thereof
#800Compositions And Methods For Prophylaxis Or Treatment Of Pain
#801TOPICAL COMPOSITIONS
#802Peptide composition for treating excitatory neurotoxicity related injuries
#803Muscular atrophy-inducing agent using hypometabolism-inducing substance T1AM, and use thereof in treating muscular hypertrophy
#804Short Proline-Rich Lipopeptide Potentiates Minocycline and Rifampicin Against Multidrug-and Extensively Drug-Resistant Pseudomonas Aeruginosa
#805Multi-functional peptides and use thereof
#806Histatins and method of use thereof
#807Pharmaceutical compositions and related methods of delivery
#808METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT NEUROPATHY
#809Immunogenic WT-1 peptides and methods of use thereof
#810PEPTIDE COMPOSITIONS AND RELATED METHODS
#811PEPTIDES AND USES THEREOF
#812Methods of treating wounds using cathepsin K inhibitors
#813Method of treating diseases
#814Treatment of cancer
#815COMPOSITIONS AND METHODS USING HIGH PROTEIN FOR INDUCTION OF AUTOPHAGY
#816COMBINATION THERAPIES USING CYCLOSPORINE AND AROMATIC CATIONIC PEPTIDES
#817Applications and formulations of optimized, modified human embryonic fertility culture media with biguanides and/or functional equivalents
#818PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF
#819LLP2A-BISPHOSPHONATE CONJUGATES FOR OSTEOPOROSIS TREATMENT
#820METHODS OF IDENTIFYING AND USING AGENTS FOR TREATING DISEASES ASSOCIATED WITH INTESTINAL BARRIER DYSFUNCTION
#821ANTIMICROBIAL PEPTIDES AND ADMIXTURES THEREOF SHOWING ANTIMICROBIAL ACTIVITY AGAINST GRAM-NEGATIVE PATHOGENS
#822PEPTIDES FOR TREATMENT AND PREVENTION OF NONALCOHOLIC FATTY LIVER DISEASE
#823Compositions and methods to protect mammalian tissue against cold and other metabolic stresses
#824Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#825Peptide inhibitors of insulin-degrading enzyme
#826PEPTIDE COMPOSITIONS AND RELATED METHODS
#827CONTROLLED-RELEASE FORMULATIONS
#828Anti-folate receptor alpha antibody conjugated with hemiasterlins
#829ALDOXORUBICIN COMBINATION TREATMENTS AND METHODS
#830Compositions for stimulation of mammalian innate immune resistance to pathogens
#831Methods and compositions for reducing growth, migration and invasiveness of brain cancer stem cells and improving survival of patients with brain tumors
#832COMPOSITIONS AND METHODS USEABLE FOR TREATMENT OF DRY EYE
#833Agents targeting inhibitor of apoptosis proteins
#834MUSCULAR ATROPHY-INDUCING AGENT USING HYPOMETABOLISM-INDUCING SUBSTANCE T1AM, AND USE THEREOF IN TREATING MUSCULAR HYPERTROPHY
#835Treatment for skeletal diseases caused by intracellular protein trafficking defects
#836B*44 restricted peptides for use in immunotherapy against cancers and related methods
#837B*44 restricted peptides for use in immunotherapy against cancers and related methods
#838Compositions and methods for invasive and non-invasive procedural skincare
#839METHODS AND MATERIALS FOR TREATING CANCER
#840Compositions and methods for managing respiratory conditions
#841Hangover alleviating composition containing conjugate of sesamol and peptide as active ingredient
#842Peptides and combination of peptides for use in immunotherapy against various tumors
#843Synthetic somatostatin receptor ligands
#844Drug Delivery Enhancement Agents
#845Epitope-targeted peptide immunostimulants
#846Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
#847Immunosuppressive agents and their use in therapy
#848Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
#849Peptides and analogs for use in the treatment of oral mucositis
#850Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#851Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#852Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#853Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#854Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#855Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#856Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#857Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#858Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#859Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#860Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#861Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
#862Methods and compositions for treatment of Gaucher Disease via modulation of C5a receptor
#863Preventive and/or therapeutic agent for osteogenesis imperfecta and other diseases
#864Use of TREM-1 inhibitors for treatment, elimination and eradication of HIV-1 infection
#865Peptides and combination of peptides for use in immunotherapy against various tumors
#866Stapled intracellular-targeting antimicrobial peptides to treat infection
#867Antiviral peptides for treatment of the middle east respiratory syndrome
#868Bioactive Metabolities Encoded by the Human Microbiome Using Primary Sequence Alone
#869Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#870Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#871Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#872Cell-permeable bone morphogenetic protein (CPBMP) recombinant protein and use thereof
#873Methods for reducing symptoms of multiple sclerosis using a six-amino acid long peptide that inhibits CD40-CD150 interaction
#874Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#875Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#876Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#877Peptide-targeted liposomal delivery for treatment, diagnosis, and imaging of diseases and disorders
#878NMR METHODS AND SYSTEMS FOR THE RAPID DETECTION OF CANDIDA SPECIES
#879Targeting Macrophages to Modulate Electrical Conduction in the Heart
#880COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD137+ CELLS
#881IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE
#882Drug delivery system containing phospholipid and cholesterol
#883Human cancer cell metastasis inhibitory agent and human cancer cell determination agent
#884PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM KINASE INHIBITORS FOR TREATMENT OF CANCERS
#885Treatments for Gastrointestinal Disorders
#886ANTI-NEURODEGENERATIVE THERAPEUTIC, METHOD OF MANUFACTURE, AND USE
#887Methods and treatments using toll-like receptor agonists to mitigate hematopoietic myeloid loss, increase gastrointestinal recovery and reduce tumor growth
#888Immunotherapeutic method for treating lung cancer by administering a polypeptide comprising an epitope of hZP3
#889Peptides for use in the treatment of viral infections
#890Use of peptides as therapeutic agent for autoimmune diseases and bone diseases
#891Methods, compositions, and kits for detection of aspergillosis
#892Interleukin 15 fusion protein for tumor targeting therapy
#893Positron emitting radionuclide labeled peptides for human uPAR PET imaging
#894Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
#895COMPOSITIONS FOR DELIVERY TO AND TREATMENT OF ATHEROSCLEROTIC PLAQUES
#896METHODS FOR ENHANCING IMMUNOTHERAPY IN THE TREATMENT OF CANCER
#897Antimicrobial compounds from the genus
#898Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#899Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#900Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers